UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	January 25, 2024

Accession Number:	0001213900-24-005752
Submission Type:	POS AM
CIK: 0001946399 Company Name: YS Biopharma Co., Ltd. File Number: 333-271221